Crystalens patients keep 3-year accommodation

Aliso Viejo, CA-Three years after implantation of the crystalens (eyeonics) accommodating IOL, 92% of patients achieved monocular near-vision acuity of J3 or better measured through the distance correction, according to follow-up results.

The results, released recently by eyeonics in accordance with FDA protocol, also show more than 90% of patients are seeing 20/25 or better for bilateral uncorrected distance vision at 1 and 3 years.

All patients showed no loss of accommodation with intermediate vision of J3 or better uncorrected intermediate vision.

"The 3-year data are a reassurance to physicians and their patients that the benefits they enjoy with the crystalens are lasting," said J. Andy Corley, chairman and chief executive officer, eyeonics.